UPDATE 1-Novartis wins approval for first U.S. biosimilar drug
March 06, 2015 at 09:55 AM EST
* Amgen seeking to block biosimilar's launch in court (Adds comment from Sandoz executive on pricing, background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.